4.6 Article

FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD)

Related references

Note: Only part of the references are listed.
Article Hematology

Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL

Praveen Anand et al.

Summary: By conducting full-length single-cell RNA sequencing, we identified two highly distinct stem-like states in early T-cell progenitor acute lymphoblastic leukemia (ETP-ALL), which differed significantly in terms of cell cycle and oncogenic signaling, as well as dependence on Notch activation and PI3K signaling. Our study revealed complex interactions between signaling programs, cellular plasticity, and immune programs in ETP-ALL, highlighting the multidimensionality of tumor heterogeneity.

BLOOD (2021)

Article Hematology

Changing trends in the therapy of acute myeloid leukemia

Jacob M. Rowe

Summary: Acute myeloid leukemia (AML) is the most common acute leukemia, characterized by pancytopenia, weakness, fatigue, infections, and hemorrhagic findings. Incidence of AML is attributed to environmental factors, genetic abnormalities, and previous treatments.

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2021)

Review Biochemistry & Molecular Biology

Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia

Anna Mroczek et al.

Summary: Acute lymphoblastic leukaemia (ALL) is a common childhood cancer with a cure rate of over 80%, diagnosed based on various features. Despite unclear pathogenesis, research focuses on new therapeutic targets and predictive factors for improved patient outcomes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia

Marta Weronika Lato et al.

Summary: Childhood acute lymphoblastic leukemia is a genetically heterogeneous cancer with T-ALL accounting for a portion. Despite the lack of genetic prognostic markers, high-throughput molecular methods have improved subgroup identification, treatment selection, and disease outcomes. Novel therapies targeting molecular aberrations offer promise in improving remission rates and preventing relapse, with nelarabine-based regimens remaining the standard for treating relapse of T-ALL.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Medicine, General & Internal

Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia

Hiroto Inaba et al.

Summary: Over the past five decades, the outcomes of pediatric acute lymphoblastic leukemia (ALL) have significantly improved, with 5-year survival rates exceeding 90% in high-income countries. The goal for the next decade is to further increase survival towards 100% and minimize treatment-related adverse effects. Genome-wide analyses have allowed for the classification of ALL into various subtypes, with treatment response and minimal residual disease analysis providing insights for new therapeutic strategies.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Oncology

Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia

Guillaume Richard-Carpentier et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)

Article Engineering, Aerospace

Basic performance and future developments of BeiDou global navigation satellite system

Yuanxi Yang et al.

SATELLITE NAVIGATION (2020)

Article Hematology

Can one target T-cell ALL?

Adolfo Ferrando

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2018)

Review Oncology

Pediatric T-Cell Acute Lymphoblastic Leukemia

Kristina Karrman et al.

GENES CHROMOSOMES & CANCER (2017)

Review Hematology

The genetics and molecular biology of T-ALL

Tiziana Girardi et al.

BLOOD (2017)

Article Education, Scientific Disciplines

T-cell acute lymphoblastic leukemia

Elizabeth A. Raetz et al.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)

Article Pediatrics

Biology of Childhood Acute Lymphoblastic Leukernia

Deepa Bhojwani et al.

PEDIATRIC CLINICS OF NORTH AMERICA (2015)

Article Multidisciplinary Sciences

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

Jinghui Zhang et al.

NATURE (2012)